Influence of dopaminergig medication and subthalamic nucleus deep brain stimulation on impulsive decision making in Parkinson’s disease
Objective: To investigate how impulsive decision making is modulated by regular dopaminergic medication and by switching between active contacts of subthalamic nucleus stimulation Background: Impulsive…Longitudinal evaluation of hypomimia in individuals with Parkinson’s disease using a video analytics tool
Objective: To assess hypomimia longitudinally in individuals with Parkinson’s disease (PD) using a video analytics tool. Background: Recent advancements in video analytics - the use…A systematic review to compare the effect of bilateral deep brain stimulation (STN versus GPI) on gait and balance in Parkinson’s disease
Objective: To compare the effect of bilateral sub-thalamic nucleus (STN) deep brain stimulation (DBS) and Globus pallidus interna (GPI) DBS on gait and postural stability in Parkinson’s…Dopamine agonist utilization prior to the initiation of device aided therapy: data from 150 patients with advanced Parkinson’s disease treated with Levodopa Carbidopa Intestinal Gel
Objective: Objective: To evaluate the usage of dopamine agonists (DA) as part of the last conventional dopaminergic treatment in a large cohort of consecutive patients…Embodied language in Parkinson disease: the case of demonstrative
Objective: Action language is recognized as impaired in Parkinson's disease (PD), proposing a functional role for the motor system in understanding action words [1]. This…The benefit of exclusive nocturnal administration of a levodopa-carbidopa intestinal infusion for severe refractory sleep behavior disorder in Parkinson’s disease
Objective: Treatment by continuous diurnal intestinal infusion of levodopa is effective in improving sleep quality in Parkinson's disease (PD), but its use exclusively at night…Estimating the Meaningful Within-Patient Change Threshold for the MDS-UPDRS Part III
Objective: To estimate the meaningful within-patient worsening threshold (MWPWT) of the Movement Disorders Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS Part III in early-stage Parkinson's disease…Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life
Objective: Objective: The goal of this study was to survey individuals with PD to evaluate whether intensity of childhood trauma is associated with individual symptoms,…Outcome and mortality of hospital admission with COVID-19 in parkinsonian syndromes
Objective: To evaluate features associated with poor outcome and mortality of COVID-19 in people with Parkinson’s disease (PD) and atypical Parkinsonian syndromes (APS) in a…Robust methods for missing covariates in longitudinal studies with application to biomarker research in Parkinson’s disease dementia
Objective: We propose a nonparametric method for handling different types of missing covariates in longitudinal studies. We show that the proposed method outperforms multiple standard…
- « Previous Page
- 1
- …
- 428
- 429
- 430
- 431
- 432
- …
- 553
- Next Page »
